Oceania Healthcare (ASX:OCA, NZE:OCA) said new sales volumes increased 29% and resales volumes rose 6% in the third quarter of the fiscal year compared with the prior-year period, according to Wednesday releases with the Australian and New Zealand bourses.
It is continuing to divest non-core sites and it is establishing a centralized team to support the delivery of long-term savings, expected to be in the range of NZ$10 million to NZ$15 million annually, reflecting the right sizing of support functions in light of divestments.
A NZ$5 million annualized cost right sizing program was completed and benefits from it are expected to be realized from fiscal 2026.
It also completed a refinance of debt facilities on Tuesday, March 4.
The firm's shares rose 6% in early trading on Wednesday on the New Zealand bourse and fell 2% on the Australian bourse.
Price (AUD): $0.60, Change: $-0.010, Percent Change: -1.64%
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。